"Receptors, Cytokine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface proteins that bind cytokines and trigger intracellular changes influencing the behavior of cells.
Descriptor ID |
D018121
|
MeSH Number(s) |
D12.776.543.750.705.852
|
Concept/Terms |
Receptors, Cytokine- Receptors, Cytokine
- Cytokine Receptors
- Cytokine Receptor
- Receptor, Cytokine
- Receptors, Cytokines
- Cytokines Receptors
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Cytokine".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Cytokine".
- Receptors, Cytokine
- Receptors, Chemokine
- Receptors, Colony-Stimulating Factor
- Receptors, Interferon
- Receptors, Interleukin
- Receptors, Oncostatin M
- Receptors, OSM-LIF
- Receptors, Thrombopoietin
- Receptors, Transforming Growth Factor beta
- Receptors, Tumor Necrosis Factor
This graph shows the total number of publications written about "Receptors, Cytokine" by people in this website by year, and whether "Receptors, Cytokine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 0 | 1 | 1 |
2009 | 1 | 0 | 1 |
2017 | 1 | 1 | 2 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Cytokine" by people in Profiles.
-
An instructive role for Interleukin-7 receptor a in the development of human B-cell precursor leukemia. Nat Commun. 2022 02 03; 13(1):659.
-
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome. Proc Natl Acad Sci U S A. 2017 05 16; 114(20):E4030-E4039.
-
Mutations in CRLF1 cause familial achalasia. Clin Genet. 2017 Jul; 92(1):104-108.
-
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Blood. 2010 Feb 04; 115(5):1006-17.
-
Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor. FEBS Lett. 2000 Feb 25; 468(2-3):120-4.